LeMaitre Vascular, Inc.

LMAT Healthcare Medical Instruments & Supplies

LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.

Revenue
+11.3%
EPS
−14.3%
Free cash flow
−25.8%
Total debt
+0.53%

Quarter to September 2026, against a year earlier

80.99 2.50 −2.99%
Market cap
$1.9B
P/E
29.7×
Fwd P/E
28.2×
Dividend yield
1.15%
F-score
6/9
Altman Z
6.99
Beneish M
−2.61
Dividend safety
93/100

LeMaitre Vascular, Inc. (LMAT) Operating cash flow

Alert me on Operating cash flow

LeMaitre Vascular, Inc.'s operating cash flow for fiscal 2025 was $81.3M, up 84.1% from $44.1M in fiscal 2024. Over the twelve months to 30 September 2026 it was $76.2M. Over the past ten years it has ranged from $11.4M (fiscal 2015) to $81.3M (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. LeMaitre Vascular, Inc. ranks 23rd of 51 Medical Instruments & Supplies companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $81.3M 84.14%
FY2024 $44.1M 20.06%
FY2023 $36.8M 44.81%
FY2022 $25.4M (27.70%)
FY2021 $35.1M 0.87%
FY2020 $34.8M 145.43%
FY2019 $14.2M (27.31%)
FY2018 $19.5M (14.70%)
FY2017 $22.9M 35.35%
FY2016 $16.9M 47.72%

Quarterly newest first

Period Operating cash flow Change
Sep 2026 $22.0M 37.74%
Jun 2026 $16.0M 5.78%
Mar 2026 $15.1M (34.82%)
Dec 2025 $23.2M (19.49%)
43 more quarters

Against its own ten years

Low $11.4M High $81.3M
Ten-year median $25.4M
Current reading's percentile 100

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on LMAT